跳至主要内容
临床试验/JPRN-jRCTs032220597
JPRN-jRCTs032220597招募中Unknown

Efficacy and safety of poly acrylic acid-poly vinylpyrrolidone complexes for bleeding time after arterial venous fistula decannulation in hemodialysis patients - PAA-PVP trial

Yamamoto Suguru0 个研究点目标入组 50 人开始时间: 2023年1月31日最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • Patients who meet all the inclusion criteria as below,
  • 1. Patients who can obtain written informed consent to participate in this study based on their free will.
  • 2. Patients who are more than 18 years old.
  • 3. Patients undergoing regular hemodialysis treatment 3 times a week and for 3-5 hours each session using internal shunt.
  • 4. Patients who use heparin as anti-coagulant for hemodialysis treatment
  • 5. Patients whose bleeding time after decannulation at the end of hemodialysis treatment is 10 minutes using regular hemostasis pad and band.

排除标准

  • Patients who meet any exclusion criteria as below.
  • 1. Patients who participate in other clinical studies.
  • 2. Patients who are pregnant or want pregnancy.
  • 3. Patients who do not use internal shunt as vascular access.
  • 4. Patients who use fingers or use band for more than 10 minutes for hemostasis after decannulation at the end of hemodialysis treatment.
  • 5. Patients who have serious skin disease.
  • 6. Patients who have the plan to start anti-coagulant/anti-platelet therapy
  • 7. Patients that the investigators decide inappropriate to join the study.

研究者

发起方
Yamamoto Suguru

相似试验